Trial Profile
A 12-Week, Randomized, Open-Label, 3 Arm Parallel Group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin Achieving NCEP ATP [National Cholesterol Education Program Adult Treatment Panel] III LDL-C [low-density lipoprotein cholesterol] Goals in High Risk Subjects With Hypercholesterolaemia in the Managed Care Setting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Apr 2008
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin; Simvastatin
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms SOLAR
- Sponsors AstraZeneca
- 17 Apr 2008 New trial record.